MS Sarah J. McPartland MD

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) can prolong survival in peritoneal-based malignancies. These malignancies harbor in visceral and omental adipose tissue, and as a result, obesity may contribute to greater tumor burden. Obesity also is an independent risk factor for perioperative complications following major(More)
  • 1